SUSTAINABLE MEDICINES PARTNERSHIP
The Sustainable Medicines Partnership (SMP) was a not-for-profit action collaborative of 48 organisations.
Between 2021-2026 we executed a programme of integrated, science-based projects to reduce waste of medicines and from medicines.
Read the overview of our outputs HERE.
4.5 trillion medicines are made every year
Billions are never used
SMP Repository
The SMP Repository is the definitive archive of the Sustainable Medicines Partnership.
It houses 30 resources, including datasets, reports, research, frameworks, articles, graphics and webinars. It is built on the Zenodo platform: a robust, open digital archive built by CERN.
All resources are open access and have a unique Digital Object Identifier (DOI), to ensure reliable, durable, access and citability.
Please download the SMP Repository - Overview and Contents, for the full list and links.
Sustainable Medicines eBook
Learn more about:
The scale and causes of wasted medicines
The Pillars and Frameworks needed to drive change.
How SMP is driving action.
Medicine Carbon Footprints
A critical barrier to making medicines more sustainable has been the lack of standardised datasets of medicine product carbon footprint data.
We developed a novel AI-driven methodology, MCF Classifier, to predict the carbon footprint of medicines, and used it to build large-scale datasets (MCF Data) and an online educational web tool (MCF Formulary).
SMP Packaging Awards
The Sustainable Medicines Packaging Awards aim to showcase innovations transforming medicines packaging today, and to inspire the innovations of tomorrow.
Design Award showcases innovations that reduce waste, and increase sustainability, without compromising function.
Circularity Award showcases services, processes, or products that bring circularity and reduce single-use packaging.
Decarbonising Medication Information
Research Publication
Transitioning to a digital-first system, as recommended by the FDA, is better for patients and the planet, reducing waste and errors.
The paper outlines the rationale and transition roadmap.